drugset / Trial / NCT03252626

Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

NCT03252626

Phase 4 Unknown 950 enrolled The First Hospital of Jilin University
RandomizedParallel-groupTriple-blindTreatment

Summary

Ischemic stroke has a variety of treatments and currently drug therapy is one of the main treatments.A number of clinical studies have proved that alprostadil (PGE1) has pharmacological effects of significant dilation of blood vessels, inhibition of plate aggregation, anti-atherosclerosis and increased cerebral blood flow.Evaluate the 90-days efficacy by comparing two groups of patients'(one with alprostadil,another with placebo) mRS.

Timeline

Start
2024-04-18
Primary completion
2024-12-31
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alprostadil Unknown 500 ug Other

Indications